BRAIDWELL LP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BRAIDWELL LP | 0 0.000% |
-3,469,674 (Position Closed) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BRAIDWELL LP | 3,469,674 6.450% |
3,469,674 (New Position) |
Filing |